相关实验视频
Updated: Jun 30, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.2K
老化疗法:一种新兴的骨关节炎治疗方式
Md Meraj Ansari1, Mrinmoy Ghosh2, Dong-Sun Lee3
1Department of Animal Biotechnology, Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju-si 63243, Republic of Korea.
Ageing research reviews
|March 17, 2024
概括
骨关节炎 (OA) 与关节的衰老和衰老细胞 (SCs) 有关. 消除SCs的老化药物显示出对管理OA进展和关节功能障碍的承诺.
科学领域:
- 老年学是指老年学的学科.
- 类风湿病学 类风湿病学
- 细胞生物学 细胞生物学
背景情况:
- 骨关节炎 (OA) 是导致超过65岁的人失去关节运动的主要原因,其特点是慢性疼痛和软骨退化.
- 细胞衰老,标志着细胞灭亡抵抗和特定的分子变化,随着年龄的增长而增加,并与OA的发病有关.
- 衰老细胞 (SCs) 在老化的关节中积累,通过诸如衰老相关分泌表型 (SASP) 这样的机制促进OA的发展和进展.
研究的目的:
- 探索驱动骨关节炎发病的与年龄相关的机制.
- 讨论衰老细胞 (SCs) 和它们相关的分泌表型在OA中的作用.
- 评估老化药物作为一种潜在的治疗策略,用于管理与年龄相关的OA.
主要方法:
- 关于衰老,细胞衰老和骨关节炎的临床前和临床研究的综述.
- 分析关节组织中与衰老相关的分子和细胞变化.
- 针对OA模型中老化细胞的老化疗法的研究.
主要成果:
- 关节组织中衰老细胞 (SCs) 的密度增加与骨关节炎的发展相关.
- 由SCs分泌的与衰老相关的分泌表型 (SASP) 与软骨分解和OA有关.
- 在临床前和临床研究中,老化剂显示出通过消除SCs来减轻OA进展的潜力.
结论:
- 衰老诱导的细胞衰老是骨关节炎发病的一个关键因素.
- 用老化药物向衰老细胞 (SCs) 为骨关节炎管理提供了一个有前途的治疗途径.
- 对与年龄有关的机制的进一步研究对于改善关节炎患者的治疗结果至关重要.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
660
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
660
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Opioid Analgesics: Synthetic and Semisynthetic Opioids
289
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
289
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K

